Factors affecting whether patients receive CAR T-cell therapy. Access barriers to CAR T-cell therapy exist at all levels of the referral-to-infusion continuum and social determinants of health affect patient access and outcomes. Access barriers translate into a smaller percentage of referred eligible individuals receiving CAR T-cell therapy, with racial and ethnic minority patients often discordantly hindered relative to NHW patients.